The Pharmaceutical industry is changing rapidly, and today’s issues and challenges are increasingly complex and difficult to resolve. A stable and predictable market is a thing of the past.
Key factors such as declining research and development (R&D) productivity, rising costs of commercialization, increasing payer and patient influence and shorter exclusivity periods have driven up the average cost per successful launch to $1.7 billion while significantly reducing ROI and growth. And emerging demographic and healthcare trends are suggesting even stronger structural changes are coming.
